1-8 of 8
Adolfo Enrique Diaz Duque, MDMSc
Close
Sort by
Journal Articles

The Role of Ethnicity in Hepatosplenic T-Cell Lymphoma: A Retrospective Survival Analysis in Texas

Leyla Bojanini Molina, MD, Joel E Michalek, PhD, Qianqian Liu, PhD, Adolfo Enrique Diaz Duque, MDMSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 19.
https://doi.org/10.1182/blood-2020-142502
Published: 2020
Journal Articles

Survival and Outcomes for T-Cell Lymphomas in a Ubiquitous Hispanic Community: A Texas Cancer Registry Retrospective Study

Gerardo Manuel Rosas, MD, Sushanth Kakarla, MBBS, Brian Warnecke, DO, Sarah Allison Smith, MD, Joel E Michalek, PhD, Qianqian Liu, PhD, Adolfo Enrique Diaz Duque, MDMSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-136223
Published: 2020
Journal Articles

Is There a Disparity in Oncological Outcomes for Hispanics? Analysis of Burkitt Lymphoma

Carolina Velez-Mejia, MD, Daniela Hernandez, MD, Joel E Michalek, PhD, Qianqian Liu, PhD, Adolfo Enrique Diaz Duque, MDMSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-136485
Published: 2020
Journal Articles

Ethnic Disparities in Hodgkin's Lymphoma (HL): A Large-Scale Population Based Analysis of Hispanics with HL in Texas

Sushanth Kakarla, MBBS, Gerardo Manuel Rosas, MD, Sarah Allison Smith, MD, Brian Warnecke, DO, Joel E Michalek, PhD, Qianqian Liu, PhD, Adolfo Enrique Diaz Duque, MDMSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-137230
Published: 2020
Journal Articles

A First Large Statewide Population Based Study Evaluating Racial Differences in Treatment and Survival between Hispanics and Non-Hispanics with Diffuse Large B Cell Lymphoma (DLBCL)

Daniela Hernandez, MD, Carolina Velez-Mejia, MD, Joel E Michalek, PhD, Qianqian Liu, PhD, Adolfo Enrique Diaz Duque, MDMSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-142151
Published: 2020
Journal Articles

Does Hispanic Origin Affect the Repartition and Outcome of Marginal Zone Lymphoma?

Lakene Raissa Djoufack Djoumessi, MD, Snegha Ananth, MBBS, Michael E Auster, DO, Joel E Michalek, PhD, Qianqian Liu, PhD, Adolfo Enrique Diaz Duque, MDMSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 12.
https://doi.org/10.1182/blood-2020-136220
Published: 2020
Journal Articles

Population Based Analysis of Mantle Cell Lymphoma in Texas: Are Outcomes Any Different in Hispanics?

Michael M. Song, MDPhDPharmD, Abhishek Pandya, DO, K Tai Lucero, MD, James J Yoo, MD, Joel E Michalek, PhD, Qianqian Liu, PhD, Adolfo Enrique Diaz Duque, MDMSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-137737
Published: 2020
Journal Articles

Demographic Differences in the Treatment and Mortality of Lymphoplasmacytic Lymphoma in Texas: Does Ethnicity Play Any Role?

Michael E Auster, DO, Snegha Ananth, MBBS, Lakene Raissa Djoufack Djoumessi, MD, Qianqian Liu, PhD, Joel E Michalek, PhD, Adolfo Enrique Diaz Duque, MDMSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–20.
https://doi.org/10.1182/blood-2020-138604
Published: 2020